Rigel Pharmaceuticals (RIGL) PT Raised to $11 at Piper Jaffray

August 30, 2016 8:53 AM EDT
Get Alerts RIGL Hot Sheet
Price: $2.20 -2.22%

Rating Summary:
    6 Buy, 5 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 30 | Down: 30 | New: 23
Trade RIGL Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Piper Jaffray analyst Joshua Schimmer reiterated an Overweight rating on Rigel Pharmaceuticals (NASDAQ: RIGL) and raised his price target to $11.00 (from $10.00) following data this morning.

For an analyst ratings summary and ratings history on Rigel Pharmaceuticals click here. For more ratings news on Rigel Pharmaceuticals click here.

Shares of Rigel Pharmaceuticals closed at $2.64 yesterday.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories

Analyst Comments, Analyst PT Change, FDA, Momentum Movers, Trader Talk

Related Entities

Piper Jaffray, Joshua Schimmer

Add Your Comment